MedPath

Gene-diet Interactions on Body Weight Regulation and Lifestyle Parameters.

Not Applicable
Completed
Conditions
Overweight and Obesity
Quality of Life
Gene-diet Interactions
Body Weight Changes
Health Status
Interventions
Other: Nutritional intervention.
Registration Number
NCT04699448
Lead Sponsor
Harokopio University
Brief Summary

Increased body weight leading to the development and the establishment of overweight and obesity, has a growing detrimental effect on overall health status and quality of life. Latest research has been focusing on the direct influence of dietary habits on body weight regulation and its synergistic effect with genetic predisposition. The synergistic effect of genetic makeup and dietary habits constitute a major contributing factor, specifically in its manifestation on parameters of the cardiometabolic profile of individuals with elevated body weight.

In this context, the aim of the present study is to investigate the effect of two hypocaloric diets with different macronutrient content (a high-carbohydrate/low-fat and a high-protein one) on the body weight loss of an overweight and/or obese adult, Greek population. Moreover, the study aims to explore gene-diet interactions between obesity and weight loss- related target genes and adherence to the proposed dietary schemes. It will further examine influences of the aforementioned factors on body composition, anthropometric indices, such as waist circumference, biochemical biomarkers related to cardiometabolic control and parameters of lifestyle, such as sleep quality.

More specifically, 300 participants will be allocated into two groups, following either the high-carbohydrate/low-fat diet or the high-protein diet, for a duration of 3 months. Volunteers will participate in in-person meetings, at baseline and at three months after the beginning of the intervention. Anthropometric measurements and collection of blood samples will take place in each meeting. Demographic data and data on family and medical history, dietary habits, adherence to the Mediterranean diet, overall health status and physical activity will be collected at baseline. Participants will be provided with nutritional counselling and support both at the beginning and throughout the intervention. Participants will further report their monthly progress by completing online questionnaires (namely concerning their body weight, overall health status, physical activity and sleep quality), via use of an online assessment tool developed by our team.

The effect of the intervention will be evaluated using anthropometric indices, body composition markers and biochemical biomarkers of cardiometabolic control, pre- and post- intervention. Gene-diet interactions will be assessed via genotyping of DNA samples and statistical analyses will take place via statistical packages, such as PLINK v.1.9.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
202
Inclusion Criteria
  • Men and women of 18 to 65 years of age.
  • Body Mass Index of over 25kg/m2 (presence of overweight or obesity)
Exclusion Criteria
  • Pregnancy or lactation.
  • Unregulated comorbidities (i.e. type 1 or 2 diabetes, cardiovascular disease, gastrointestinal disorders, mental illness, dietary disorders)
  • Dietary supplements aiming at body weight loss
  • Parallel participation in a different research study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High-protein hypocaloric dietNutritional intervention.Composition of hypocaloric diet: protein:40%,carbohydrates:30% and fat:30%.
High-carbohydrate hypocaloric dietNutritional intervention.Composition of hypocaloric diet: carbohydrate 60%, protein:18% and fat:22%
Primary Outcome Measures
NameTimeMethod
Body Weight3 months

Changes in body weight compared to baseline.

Secondary Outcome Measures
NameTimeMethod
Waist circumference3 months

Changes in waist circumference compared to baseline.

Biochemical profile3 months

Changes in biochemical biomarkers related to metabolic syndrome and cardiovascular disease risk (i.e. total cholesterol, glucose, triglyceride and HDL levels) compared to baseline.

Body fat percentage3 months

Changes in body fat percentage compared to baseline.

Visceral fat3 months

Changes in visceral fat compared to baseline.

Sleep quality3 months

Changes in sleep quality characteristics compared to baseline. Assessment will take place via use of validated questionnaire.

Overall health status3 months

Changes in the overall health status compared to baseline. Assessment will take place via use of validated questionnaire.

Trial Locations

Locations (1)

Harokopio University

🇬🇷

Athens, Kallithea, Greece

© Copyright 2025. All Rights Reserved by MedPath